Low-dose methotrexate has shown potential for treating symptoms of myeloproliferative neoplasms such as fatigue and night sweats. A series of case studies published in the British Journal of Haematology in patients with myeloproliferative neoplasms taking the drug for other reasons showed unintended benefits of methotrexate in symptom management. The researchers reported findings from 11 patients ...
Methotrexate shows promise for symptoms of myeloproliferative neoplasms
24 Sep 2019